{
    "nctId": "NCT05253170",
    "briefTitle": "Hypo Versus Conventional Fractionation in Reconstructed-Breast Cancer Mastectomy Patients",
    "officialTitle": "A Randomized Phase III Trial of Hypofractionated Versus Conventionally Fractionated Radiotherapy in Breast Cancer Patients With Reconstruction After Mastectomy",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Breast Cancer, Radiotherapy; Complications",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 622,
    "primaryOutcomeMeasure": "Major Complication Rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patient who underwent mastectomy for invasive breast cancer\n* Patients who have undergone breast reconstruction after mastectomy or who have inserted a tissue expander\n* (y)p patients with stage IIIA or lower (excluding T4 and N3 patients) who need adjuvant radiation therapy\n* Eastern Cooperative Oncology Group Performance \u2264 2\n* Age \u2265 19 years\n* Patients who agreed to participate in the study\n\nExclusion Criteria:\n\n* Patients who already had implants at the time of diagnosis of breast cancer or who have already undergone reconstructive surgery\n* Patients who underwent reconstruction after partial resection or breast conserving surgery rather than mastectomy\n* Patients who are using or planning to use an air expander\n* Patients receiving radiation therapy for salvage or palliative purposes\n* Patients with distant metastases at the time of diagnosis\n* Patients who are scheduled to undergo concurrent chemoradiation therapy\n* Patients with bilateral breast cancer\n* Male breast cancer patients\n* Patients who have previously received radiation therapy for the ipsilateral breast or supraclavicular area\n* Patients with history of cancers other than thyroid cancer, intraepithelial cancer of the cervix, or skin cancer\n* Patients diagnosed with ductal breast carcinoma in situ, lobular carcinoma in situ, phyllodes, metaplastic cancer, or other benign tumors based on histological diagnosis",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}